Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Nadolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1 Carcinoma, Hepatocellular 1

Interventions

Metformin 12 Drug Therapy 11 Cyclophosphamide 11 Dexamethasone 10 Cytarabine 10 Cisplatin 10 Carboplatin 8 icotinib 7 Sodium Chloride 7 Radiotherapy 7 Oxaliplatin 7 Docetaxel 7 ulipristal acetate 6 Vincristine 6 Paclitaxel 6 Gemcitabine 6 Fluorouracil 6 Dexmedetomidine 6 entecavir 5 Thalidomide 5 Surgical Procedures, Operative 5 S 1 (combination) 5 Propranolol 5 Pemetrexed 5 Methotrexate 5 Leuprolide 5 Idarubicin 5 Granulocyte Colony-Stimulating Factor 5 Endostatins 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00567216 2010-06-08

GVO-nadolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡